SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-23-037217
Filing Date
2023-02-14
Accepted
2023-02-14 07:33:52
Documents
2
Group Members
ANTARA CAPITAL GP LLCHIMANSHU GULATI

Document Format Files

Seq Description Document Type Size
1 SC 13G d431111dsc13g.htm SC 13G 73707
2 EX-99.1 d431111dex991.htm EX-99.1 7912
  Complete submission text file 0001193125-23-037217.txt   83200
Mailing Address 1222 DEMONBREUN STREET SUITE 2000 NASHVILLE TN 37203
Business Address 1222 DEMONBREUN STREET SUITE 2000 NASHVILLE TN 37203 6157247755
Revance Therapeutics, Inc. (Subject) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88023 | Film No.: 23622453
SIC: 2834 Pharmaceutical Preparations

Mailing Address 55 HUDSON YARDS 47TH FLOOR NEW YORK NY 10001
Business Address 55 HUDSON YARDS 47TH FLOOR NEW YORK NY 10001 646-762-8580
Antara Capital LP (Filed by) CIK: 0001750183 (see all company filings)

IRS No.: 824823093 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G